NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)
Close on Nov 17, 2026Market cap $1.97BP/E –Yield –
NeoGenomics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
NeoGenomics's total debt was $374.69M at Sep 30, 2026. For fiscal 2025 it was $341.86M, down 36.8% from the year before. Over ten years it grew 18.5% a year on average. The highest annual figure on record is $541.11M in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $341.86M | -36.8% |
| FY2024 | Dec 31, 2024 | $541.11M | +0.5% |
| FY2023 | Dec 31, 2023 | $538.20M | +0.5% |
| FY2022 | Dec 31, 2022 | $535.39M | +0.3% |
| FY2021 | Dec 31, 2021 | $533.69M | +215.6% |
| FY2020 | Dec 31, 2020 | $169.09M | +69.0% |
| FY2019 | Dec 31, 2019 | $100.03M | -10.9% |
| FY2018 | Dec 31, 2018 | $112.30M | +6.5% |
| FY2017 | Dec 31, 2017 | $105.42M | -0.7% |
| FY2016 | Dec 31, 2016 | $106.17M | +69.8% |
| FY2015 | Dec 31, 2015 | $62.51M | +1797.7% |
| FY2013 | Dec 31, 2013 | $3.29M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $374.69M | -30.4% |
| Q2 FY2026 | Jun 30, 2026 | $374.24M | -30.1% |
| Q4 FY2025 | Dec 31, 2025 | $341.86M | -35.9% |
| Q4 FY2024 | Dec 31, 2024 | $541.11M | +1.4% |
| Q4 FY2023 | Dec 31, 2023 | $538.20M | +0.9% |
| Q4 FY2022 | Dec 31, 2022 | $535.39M | +0.4% |
| Q4 FY2021 | Dec 31, 2021 | $533.69M | +215.6% |
| Q3 FY2021 | Sep 30, 2021 | $533.50M | +217.9% |
| Q2 FY2021 | Jun 30, 2021 | $533.44M | +220.5% |
| Q1 FY2021 | Mar 31, 2021 | $533.15M | +417.8% |
| Q4 FY2020 | Dec 31, 2020 | $169.09M | +69.0% |
| Q3 FY2020 | Sep 30, 2020 | $167.84M | +54.0% |
| Q2 FY2020 | Jun 30, 2020 | $166.45M | +51.5% |
| Q1 FY2020 | Mar 31, 2020 | $102.97M | -6.9% |
| Q4 FY2019 | Dec 31, 2019 | $100.03M | -10.9% |
| Q3 FY2019 | Sep 30, 2019 | $109.01M | -1.2% |
| Q2 FY2019 | Jun 30, 2019 | $109.86M | -20.7% |
| Q1 FY2019 | Mar 31, 2019 | $110.62M | +9.5% |
| Q4 FY2018 | Dec 31, 2018 | $112.30M | +6.5% |
| Q3 FY2018 | Sep 30, 2018 | $110.32M | +5.0% |
| Q2 FY2018 | Jun 30, 2018 | $138.53M | +26.7% |
| Q1 FY2018 | Mar 31, 2018 | $101.04M | +1.2% |
| Q4 FY2017 | Dec 31, 2017 | $105.42M | -0.7% |
| Q3 FY2017 | Sep 30, 2017 | $105.06M | – |
| Q2 FY2017 | Jun 30, 2017 | $109.31M | – |
| Q1 FY2017 | Mar 31, 2017 | $99.88M | – |
| Q4 FY2016 | Dec 31, 2016 | $106.17M | – |
See a number that looks wrong?